Stockreport

Beam Therapeutics Announces Pricing of Initial Public Offering

Beam Therapeutics Inc.  (BEAM) 
PDF CAMBRIDGE, Mass.--(BUSINESS WIRE)--Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today [Read more]